p53-Dependent transcriptional control of cellular prion by presenilins

J Neurosci. 2009 May 20;29(20):6752-60. doi: 10.1523/JNEUROSCI.0789-09.2009.

Abstract

The presenilin-dependent gamma-secretase processing of the beta-amyloid precursor protein (betaAPP) conditions the length of the amyloid beta peptides (Abeta) that accumulate in the senile plaques of Alzheimer's disease-affected brains. This, together with an additional presenilin-mediated epsilon-secretase cleavage, generates intracellular betaAPP-derived fragments named amyloid intracellular domains (AICDs) that regulate the transcription of several genes. We establish that presenilins control the transcription of cellular prion protein (PrP(c)) by a gamma-secretase inhibitor-sensitive and AICD-mediated process. We demonstrate that AICD-dependent control of PrP(c) involves the tumor suppressor p53. Thus, p53-deficiency abolishes the AICD-mediated control of PrP(c) transcription. Furthermore, we show that p53 directly binds to the PrP(c) promoter and increases its transactivation. Overall, our study unravels a transcriptional regulation of PrP(c) by the oncogene p53 that is directly driven by presenilin-dependent formation of AICD. Furthermore, it adds support to previous reports linking secretase activities involved in betaAPP metabolism to the physiology of PrP(c).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid Precursor Protein Secretases / genetics
  • Amyloid Precursor Protein Secretases / metabolism
  • Amyloid beta-Protein Precursor / deficiency
  • Amyloid beta-Protein Precursor / genetics
  • Animals
  • Brain / metabolism
  • Cells, Cultured
  • Chromatin Immunoprecipitation / methods
  • Cyclin-Dependent Kinase Inhibitor p19 / deficiency
  • Cyclin-Dependent Kinase Inhibitor p19 / genetics
  • Dipeptides / pharmacology
  • Embryo, Mammalian
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Humans
  • Mice
  • Mice, Knockout
  • Mutagenesis, Site-Directed / methods
  • Presenilins / deficiency
  • Presenilins / metabolism*
  • Prions / metabolism*
  • Protein Structure, Tertiary / genetics
  • RNA, Messenger / metabolism
  • Transfection / methods
  • Tumor Suppressor Protein p53 / deficiency
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Amyloid beta-Protein Precursor
  • Aplp2 protein, mouse
  • Cdkn2d protein, mouse
  • Cyclin-Dependent Kinase Inhibitor p19
  • Dipeptides
  • Enzyme Inhibitors
  • N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester
  • Presenilins
  • Prions
  • RNA, Messenger
  • Tumor Suppressor Protein p53
  • Amyloid Precursor Protein Secretases